User profiles for C. Marcelo Aldaz

C. Marcelo Aldaz

Professor, The University of Texas MD Anderson Cancer Center
Verified email at mdanderson.org
Cited by 10808

WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23. 3–24.1, a region frequently affected in breast cancer

…, KJ Laflin, RL Daniel, Q Liao, KA Hawkins, CM Aldaz - Cancer research, 2000 - AACR
Studies were conducted with the final goal of identifying genes of interest mapping to the
chromosome region 16q23.3–24.1, an area commonly affected by allelic losses in breast …

WWOX , the FRA16D Gene, Behaves as a Suppressor of Tumor Growth

…, PL Bergsagel, K Kiguchi, AJ Brenner, CM Aldaz - Cancer research, 2001 - AACR
We recently reported the cloning of WWOX, a gene that maps to the common fragile site
FRA16D region in chromosome 16q23.3-24.1. It was observed that the genomic area spanned …

Differential expression in SAGE: accounting for normal between-library variation

KA Baggerly, L Deng, JS Morris, CM Aldaz - Bioinformatics, 2003 - academic.oup.com
Motivation: In contrasting levels of gene expression between groups of SAGE libraries, the
libraries within each group are often combined and the counts for the tag of interest summed, …

Specific protein methylation defects and gene expression perturbations in coactivator-associated arginine methyltransferase 1-deficient mice

…, J Kim, J Shen, MCT Hu, CM Aldaz… - Proceedings of the …, 2003 - National Acad Sciences
Arginine methylation has been implicated in the regulation of gene expression. The
coactivator-associated arginine methyltransferase 1 (CARM1/PRMT4) binds the p160 family of …

Increased p16 expression with first senescence arrest in human mammary epithelial cells and extended growth capacity with p16 inactivation

AJ Brenner, MR Stampfer, CM Aldaz - Oncogene, 1998 - nature.com
Aberrations affecting the tumor suppressor gene p16 INK4a have been described for a variety
of tumors. In breast cancer, approximately 50% of tumors show low or lack p16 expression…

[HTML][HTML] Therapeutically activating RB: reestablishing cell cycle control in endocrine therapy-resistant breast cancer

…, A Ertel, KE Knudsen, CM Aldaz… - Endocrine-related …, 2011 - erc.bioscientifica.com
The majority of estrogen receptor (ER)-positive breast cancers are treated with endocrine
therapy. While this is effective, acquired resistance to therapies targeted against ER is a major …

Effects of estrogen on global gene expression: identification of novel targets of estrogen action

…, KJ Laflin, S Gaddis, MC MacLeod, CM Aldaz - Cancer research, 2000 - AACR
The important role played by the sex hormone estrogen in disease and physiological
processes has been well documented. However, the mechanisms by which this hormone elicits …

Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability.

LA Donehower, LA Godley, CM Aldaz… - Genes & …, 1995 - genesdev.cshlp.org
By crossing mice that carry a null allele of p53 with transgenic mice that develop mammary
adenocarcinomas under the influence of a Wnt-1 transgene, we have studied the …

Breast cancer molecular signatures as determined by SAGE: correlation with lymph node status

…, S Gaddis, T Shi, S Horvath, A Sahin, CM Aldaz - Molecular Cancer …, 2007 - AACR
Global gene expression measured by DNA microarray platforms have been extensively
used to classify breast carcinomas correlating with clinical characteristics, including outcome. …

[HTML][HTML] Transcriptomic changes in human breast cancer progression as determined by serial analysis of gene expression

…, S Gaddis, A Sahin, K Baggerly, CM Aldaz - Breast Cancer …, 2004 - Springer
Introduction Genomic and transcriptomic alterations affecting key cellular processes such us
cell proliferation, differentiation and genomic stability are considered crucial for the …